USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Orexo AB

USPTO PatentsView assignee record - 28 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

RSS updates for this company

The verdict

According to USPTO PatentsView, Orexo ranks #11,035 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 6 technology areas.

#11,035
of 49,997 US assignees by volume
Top 37%
by Innovation Score (40.0/100)
21.7
avg claims per patent
+27%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11035 · Foreign Corporation #11,035 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-UP · BOOK-FULL

  • GRANTS-SMALL 28 grants
  • UPPER-Q #11,035/49,997
  • PHOTO-FINISH NuCana
  • CPC-NARROW A61K · 6 areas
  • INNOV-THIN 40.0/100
  • CLAIMS-DENSE 21.7 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-UP +27% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: NuCana plc (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Orexo’s 40.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Orexo

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Orexo's Innovation Score is 40.0/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Orexo?

Each dot is one of Orexo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Orexo’s own 21.7 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Orexo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 27.92828.1 51015202530 Granted patents (volume) Avg claims / patent NuCana plc - 28, 15.96NucanaO2 Partners, LLC - 28, 8.82O2 PartnersOndal Medical Systems GMBH - 28, 15.96Ondal Medical Sys…Opko Biologics Ltd. - 28, 18.86Opko BiologicsORTHOsoft, Inc. - 28, 15.04OrthosoftOnanon, Inc. - 28, 28.43OnanonOpel Solar, Inc. - 28, 17.68Opel SolarOpen Text GXS ULC - 28, 20.32Open Text GXS ULCOrexo AB - 28, 21.68Orexo AB
Orexo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Orexo's grants concentrate

Orexo AB is a focused PatentsView assignee: 6 CPC subclasses with 89.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2022. By volume, Orexo sits between NuCana plc and Open Text GXS ULC.

Orexo's three-year grant acceleration

Orexo AB shows 7 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Orexo's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Orexo holds 28 patents at rank #11,030, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Orexo

By rank, the assignees closest to #11,030 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Orexo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Orexo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Orexo ranks #906 of 7,163 assignees by patent count in that subclass.

Orexo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 201520162017202020212022202320242025 3
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Orexo AB patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 14.3%
2016 5 17.9%
2017 2 7.1%
2020 3 10.7%
2021 4 14.3%
2022 1 3.6%
2023 2 7.1%
2024 4 14.3%
2025partial year 3 10.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Orexo AB's patent record in context - here's where to go next.

  • Orexo AB's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 89.3% of its portfolio - see every assignee active in that class. Explore A61K
  • Ranked #11,035 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Orexo AB against NuCana plc, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 40.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.